Table 2. Correlation Between Clinical Activity Score of Patients With GO and the Indicated Featuresa.
| Variable | Linear Regression | Multiple Regressionb | ||
|---|---|---|---|---|
| R (95% CI) | P Value | R (95% CI) | P Value | |
| Total No. of lymphocytesc | 0.63 (0.27 to 0.84) | .003 | 0.58 (0.18 to 0.82) | .01 |
| CD3-positive cells | 0.59 (0.20 to 0.82) | .006 | 0.58 (0.17 to 0.82) | .01 |
| CD20-positive cells | 0.65 (0.30 to 0.85) | .002 | 0.59 (0.19 to 0.83) | .01 |
| Smoking habitsd | −0.63 (−0.84 to −0.25) | .003 | NA | NA |
| vs Total No./GO duration | NA | NA | −0.43 (−0.73 to 0.01) | .08 |
| vs CD3/GO duration | NA | NA | −0.43 (−0.73 to 0.01) | .09 |
| vs CD20/GO duration | NA | NA | −0.44 (−0.74 to 0.003) | .08 |
| GO duration | −0.70 (−0.88 to −0.36) | <.001 | NA | NA |
| vs Total No./smoking | NA | NA | 0.68 (−0.86 to −0.34) | .002 |
| vs CD3/smoking | NA | NA | −0.69 (−0.87 to −0.36) | <.001 |
| vs CD20/smoking | NA | NA | −0.68 (−0.86 to 0.34) | <.001 |
Abbreviations: GO, Graves orbitopathy; NA, not applicable.
a
Population included 20 white patients (8 men, 12 women; mean [SD] age, 46 [13 years]).
b
Multiple regressions were performed individually.
c
For lymphocytes, log10 values were used.
d
Smoking habits were converted into continuous values.